Mar 08, 2022 / 09:30PM GMT
Operator
Good afternoon, and thank you for joining Cumberland Pharmaceuticals 2021 Financial Report and Company Update. This call is being recorded at the company's request and will be archived on Cumberland's website for 1 week from today's date.
I would now like to introduce Molly Aggas, Account Supervisor of the Dalton Agency, who handles Cumberland's communications. Molly, please go ahead.
Molly Aggas -
Hi, everyone. Good afternoon. Earlier today, Cumberland issued a press release announcing the company's annual financial results as well as an operational update for the year ending December 31, 2021. The release includes related financial tables and can be found on Cumberland's website at www.cumberlandpharma.com. Company management will provide an overview of these results and the recent developments during today's call.
With us today are A.J. Kazimi, Cumberland's Chief Executive Officer; Todd Anthony, Vice President, Organizational Development; and John Hamm, Chief Financial Officer
Q4 2021 Cumberland Pharmaceuticals Inc Earnings Call Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers